BioTalk is a news hub brought to you by Bird & Bird's International Life Sciences & Healthcare Group. Read more about us >

Welcome to BioTalk!

General 1 min
October 30, 2019

BioTalk, is the new hub brought to you by Bird & Bird’s International Life Sciences and Healthcare Group.

At Bird & Bird, we are passionate about Life sciences and Healthcare. We are delighted to launch our BioTalk online, so that we can bring you up to date news from across the Life sciences and Healthcare world, all in a more accessible and searchable way.

In BioTalk we will further inform you about legal and industry related news, in a user-friendly and dynamic way, proposing pragmatic advice and commentary by our experts and highlighting the important cases as well as the significant changes in law.

It features contributions of our renowned Life Sciences and Healthcare team composed by IP, Regulatory, Commercial, Corporate, Privacy and Competition specialists across Europe, Asia-Pacific and the Middle-East.

We hope you will appreciate our new format and should you want to be in touch with our editorial team, or would like to have further information about Bird & Bird’s International Life Sciences and Healthcare Group, please do not hesitate to contact us [here].

Written by
Marc Martens
Marc Martens
About me As co-head of our International Life Sciences & Healthcare group and head of Bird & Bird's Regulatory, Public & Administrative Law group in Brussels, I provide cutting edge strategic and regulatory advice to our life sciences clients and represent them in litigation.
Mark Hilton
Mark Hilton
I am a partner in our international Intellectual Property Group and co-head of our International Life Sciences & Healthcare Group. I'm based in London. As a partner in our Intellectual Property Group, I specialise in patent litigation and advise in the area of pharmaceuticals, biosimilars, biotechnology (including in food), chemicals and medical devices. However, my interests and experience also extend to a diverse range of technical fields including the financial services sector.

Related articles

Changes in the Polish Industrial Law concerning Patents
Recent changes to the Polish Industrial Law concerning patents (enacted in October 2019), are due to...
French Healthtech in the Covid crisis: when strategic issues lead to growth
The strategic challenges of the French Healthtech sector - health, innovation, sovereignty - are undeniably...